$11.36
Sotera Health Company
Performance
Dividends
1W
1M
YTD
1Y
3Y
11/36
Growth
Score
8/36
Dividend
Score
Valuation
PE Ratio
129
PS Ratio
2.91
RSI
-
0
PEG Ratio
-0.01
2
PRG Ratio
0.58
PDG Ratio
0
Growth
2023
2024
2025*
2026*
3
Revenue
Revenue
*Analyst estimated growth
Fundamentals
3
Rule
of 40
57.51%
2
Gross Margin
53.78%
2
Current Ratio
2.46
Return on Assets
0.8%
Return on Equity
5.8%
Return on inv. Capital
3.02%
Institutional Holder
Shares
Holders
Financials
Yealy
Quarterly
Revenue 2024 1.10B
2019
2020
2021
2022
2023
2024
5
Net Income 2024 44.40M
2019
2020
2021
2022
2023
2024
5
Gross Profit 2024 602.29M
2019
2020
2021
2022
2023
2024
5
Events
SHC
Sotera Health Company
in 272 days
before market open
Earnings per Share is expected with - and revenue with - .
SHC
Sotera Health Company
in 209 days
before market open
Earnings per Share is expected with - and revenue with - .
SHC
Sotera Health Company
in 95 days
before market open
Earnings per Share is expected with - and revenue with - .
About
Sector/Industry
Healthcare
Medical - Diagnostics & Research
IPO Date
20.11.2020
MaketCap
3.22B
Country
US
CEO
Michael B. Petras Jr.
Description
Sotera Health Company provides sterilization, and lab testing and advisory services in the United States, Canada, Europe, and internationally. The company's sterilization services include gamma and electron beam irradiation, and EO processing; Nelson Labs comprise microbiological and analytical chemistry testing; and advisory services for medical device and biopharmaceutical industries. It serves medical devices; pharmaceuticals; food and agricultural products; and commercial, advanced, and specialty application industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2017 and is headquartered in Broadview Heights, Ohio.
Updated 23.07.2025